img

Global Anticoagulant Medicines Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Anticoagulant Medicines Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Anticoagulant Medicines are pharmaceutical drugs used to prevent or reduce the formation of blood clots in the body, helping to prevent conditions like deep vein thrombosis and stroke.
Anticoagulant Medicines report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Anticoagulant Medicines market is projected to reach US$ 44170 million in 2029, increasing from US$ 24350 million in 2022, with the CAGR of 9.0% during the period of 2024 to 2029. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Anticoagulant Medicines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Abbott Laboratories
Aspen
AstraZeneca
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Daiichi Sankyo
Genentech (Roche)
Johnson & Johnson.
Lilly
Merck
Otsuka
Pfizer
Sanofi
The Medicines Company
Segment by Type
Injectable Anticoagulant Medicines
Oral Anticoagulant Medicines

Segment by Application


Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Anticoagulant Medicines market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Anticoagulant Medicines introduction, etc. Anticoagulant Medicines Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Anticoagulant Medicines market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Anticoagulant Medicines
1.1 Anticoagulant Medicines Market Overview
1.1.1 Anticoagulant Medicines Product Scope
1.1.2 Anticoagulant Medicines Market Status and Outlook
1.2 Global Anticoagulant Medicines Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Anticoagulant Medicines Market Size by Region (2018-2029)
1.4 Global Anticoagulant Medicines Historic Market Size by Region (2018-2024)
1.5 Global Anticoagulant Medicines Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Anticoagulant Medicines Market Size (2018-2029)
1.6.1 North America Anticoagulant Medicines Market Size (2018-2029)
1.6.2 Europe Anticoagulant Medicines Market Size (2018-2029)
1.6.3 Asia-Pacific Anticoagulant Medicines Market Size (2018-2029)
1.6.4 Latin America Anticoagulant Medicines Market Size (2018-2029)
1.6.5 Middle East & Africa Anticoagulant Medicines Market Size (2018-2029)
2 Anticoagulant Medicines Market by Type
2.1 Introduction
2.1.1 Injectable Anticoagulant Medicines
2.1.2 Oral Anticoagulant Medicines
2.2 Global Anticoagulant Medicines Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Anticoagulant Medicines Historic Market Size by Type (2018-2024)
2.2.2 Global Anticoagulant Medicines Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Anticoagulant Medicines Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Anticoagulant Medicines Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Anticoagulant Medicines Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Anticoagulant Medicines Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Anticoagulant Medicines Revenue Breakdown by Type (2018-2029)
3 Anticoagulant Medicines Market Overview by Application
3.1 Introduction
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 Online Pharmacies
3.1.4 Others
3.2 Global Anticoagulant Medicines Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Anticoagulant Medicines Historic Market Size by Application (2018-2024)
3.2.2 Global Anticoagulant Medicines Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Anticoagulant Medicines Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Anticoagulant Medicines Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Anticoagulant Medicines Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Anticoagulant Medicines Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Anticoagulant Medicines Revenue Breakdown by Application (2018-2029)
4 Anticoagulant Medicines Competition Analysis by Players
4.1 Global Anticoagulant Medicines Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anticoagulant Medicines as of 2022)
4.3 Date of Key Players Enter into Anticoagulant Medicines Market
4.4 Global Top Players Anticoagulant Medicines Headquarters and Area Served
4.5 Key Players Anticoagulant Medicines Product Solution and Service
4.6 Competitive Status
4.6.1 Anticoagulant Medicines Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Anticoagulant Medicines Products, Services and Solutions
5.1.4 Abbott Laboratories Anticoagulant Medicines Revenue (US$ Million) & (2018-2024)
5.1.5 Abbott Laboratories Recent Developments
5.2 Aspen
5.2.1 Aspen Profile
5.2.2 Aspen Main Business
5.2.3 Aspen Anticoagulant Medicines Products, Services and Solutions
5.2.4 Aspen Anticoagulant Medicines Revenue (US$ Million) & (2018-2024)
5.2.5 Aspen Recent Developments
5.3 AstraZeneca
5.3.1 AstraZeneca Profile
5.3.2 AstraZeneca Main Business
5.3.3 AstraZeneca Anticoagulant Medicines Products, Services and Solutions
5.3.4 AstraZeneca Anticoagulant Medicines Revenue (US$ Million) & (2018-2024)
5.3.5 Bayer Recent Developments
5.4 Bayer
5.4.1 Bayer Profile
5.4.2 Bayer Main Business
5.4.3 Bayer Anticoagulant Medicines Products, Services and Solutions
5.4.4 Bayer Anticoagulant Medicines Revenue (US$ Million) & (2018-2024)
5.4.5 Bayer Recent Developments
5.5 Boehringer Ingelheim
5.5.1 Boehringer Ingelheim Profile
5.5.2 Boehringer Ingelheim Main Business
5.5.3 Boehringer Ingelheim Anticoagulant Medicines Products, Services and Solutions
5.5.4 Boehringer Ingelheim Anticoagulant Medicines Revenue (US$ Million) & (2018-2024)
5.5.5 Boehringer Ingelheim Recent Developments
5.6 Bristol-Myers Squibb
5.6.1 Bristol-Myers Squibb Profile
5.6.2 Bristol-Myers Squibb Main Business
5.6.3 Bristol-Myers Squibb Anticoagulant Medicines Products, Services and Solutions
5.6.4 Bristol-Myers Squibb Anticoagulant Medicines Revenue (US$ Million) & (2018-2024)
5.6.5 Bristol-Myers Squibb Recent Developments
5.7 Daiichi Sankyo
5.7.1 Daiichi Sankyo Profile
5.7.2 Daiichi Sankyo Main Business
5.7.3 Daiichi Sankyo Anticoagulant Medicines Products, Services and Solutions
5.7.4 Daiichi Sankyo Anticoagulant Medicines Revenue (US$ Million) & (2018-2024)
5.7.5 Daiichi Sankyo Recent Developments
5.8 Genentech (Roche)
5.8.1 Genentech (Roche) Profile
5.8.2 Genentech (Roche) Main Business
5.8.3 Genentech (Roche) Anticoagulant Medicines Products, Services and Solutions
5.8.4 Genentech (Roche) Anticoagulant Medicines Revenue (US$ Million) & (2018-2024)
5.8.5 Genentech (Roche) Recent Developments
5.9 Johnson & Johnson.
5.9.1 Johnson & Johnson. Profile
5.9.2 Johnson & Johnson. Main Business
5.9.3 Johnson & Johnson. Anticoagulant Medicines Products, Services and Solutions
5.9.4 Johnson & Johnson. Anticoagulant Medicines Revenue (US$ Million) & (2018-2024)
5.9.5 Johnson & Johnson. Recent Developments
5.10 Lilly
5.10.1 Lilly Profile
5.10.2 Lilly Main Business
5.10.3 Lilly Anticoagulant Medicines Products, Services and Solutions
5.10.4 Lilly Anticoagulant Medicines Revenue (US$ Million) & (2018-2024)
5.10.5 Lilly Recent Developments
5.11 Merck
5.11.1 Merck Profile
5.11.2 Merck Main Business
5.11.3 Merck Anticoagulant Medicines Products, Services and Solutions
5.11.4 Merck Anticoagulant Medicines Revenue (US$ Million) & (2018-2024)
5.11.5 Merck Recent Developments
5.12 Otsuka
5.12.1 Otsuka Profile
5.12.2 Otsuka Main Business
5.12.3 Otsuka Anticoagulant Medicines Products, Services and Solutions
5.12.4 Otsuka Anticoagulant Medicines Revenue (US$ Million) & (2018-2024)
5.12.5 Otsuka Recent Developments
5.13 Pfizer
5.13.1 Pfizer Profile
5.13.2 Pfizer Main Business
5.13.3 Pfizer Anticoagulant Medicines Products, Services and Solutions
5.13.4 Pfizer Anticoagulant Medicines Revenue (US$ Million) & (2018-2024)
5.13.5 Pfizer Recent Developments
5.14 Sanofi
5.14.1 Sanofi Profile
5.14.2 Sanofi Main Business
5.14.3 Sanofi Anticoagulant Medicines Products, Services and Solutions
5.14.4 Sanofi Anticoagulant Medicines Revenue (US$ Million) & (2018-2024)
5.14.5 Sanofi Recent Developments
5.15 The Medicines Company
5.15.1 The Medicines Company Profile
5.15.2 The Medicines Company Main Business
5.15.3 The Medicines Company Anticoagulant Medicines Products, Services and Solutions
5.15.4 The Medicines Company Anticoagulant Medicines Revenue (US$ Million) & (2018-2024)
5.15.5 The Medicines Company Recent Developments
6 North America
6.1 North America Anticoagulant Medicines Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Anticoagulant Medicines Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Anticoagulant Medicines Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Anticoagulant Medicines Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Anticoagulant Medicines Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Anticoagulant Medicines Market Dynamics
11.1 Anticoagulant Medicines Industry Trends
11.2 Anticoagulant Medicines Market Drivers
11.3 Anticoagulant Medicines Market Challenges
11.4 Anticoagulant Medicines Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Anticoagulant Medicines Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Anticoagulant Medicines Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Anticoagulant Medicines Market Size Share by Region (2018-2024)
Table 4. Global Anticoagulant Medicines Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Anticoagulant Medicines Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Anticoagulant Medicines Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Anticoagulant Medicines Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Anticoagulant Medicines Revenue Market Share by Type (2018-2024)
Table 9. Global Anticoagulant Medicines Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Anticoagulant Medicines Revenue Market Share by Type (2024-2029)
Table 11. North America Anticoagulant Medicines Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Anticoagulant Medicines Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Anticoagulant Medicines Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Anticoagulant Medicines Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Anticoagulant Medicines Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Anticoagulant Medicines Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Anticoagulant Medicines Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Anticoagulant Medicines Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Anticoagulant Medicines Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Anticoagulant Medicines Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Anticoagulant Medicines Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Anticoagulant Medicines Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Anticoagulant Medicines Revenue Market Share by Application (2018-2024)
Table 24. Global Anticoagulant Medicines Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Anticoagulant Medicines Revenue Market Share by Application (2024-2029)
Table 26. North America Anticoagulant Medicines Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Anticoagulant Medicines Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Anticoagulant Medicines Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Anticoagulant Medicines Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Anticoagulant Medicines Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Anticoagulant Medicines Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Anticoagulant Medicines Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Anticoagulant Medicines Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Anticoagulant Medicines Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Anticoagulant Medicines Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Anticoagulant Medicines Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Anticoagulant Medicines Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anticoagulant Medicines as of 2022)
Table 39. Date of Key Players Enter into Anticoagulant Medicines Market
Table 40. Global Anticoagulant Medicines Key Players Headquarters and Area Served
Table 41. Anticoagulant Medicines Product Solution and Service
Table 42. Global Anticoagulant Medicines Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Abbott Laboratories Basic Information List
Table 45. Abbott Laboratories Description and Business Overview
Table 46. Abbott Laboratories Anticoagulant Medicines Products, Services and Solutions
Table 47. Revenue (US$ Million) in Anticoagulant Medicines Business of Abbott Laboratories (2018-2024)
Table 48. Abbott Laboratories Recent Developments
Table 49. Aspen Basic Information List
Table 50. Aspen Description and Business Overview
Table 51. Aspen Anticoagulant Medicines Products, Services and Solutions
Table 52. Revenue (US$ Million) in Anticoagulant Medicines Business of Aspen (2018-2024)
Table 53. Aspen Recent Developments
Table 54. AstraZeneca Basic Information List
Table 55. AstraZeneca Description and Business Overview
Table 56. AstraZeneca Anticoagulant Medicines Products, Services and Solutions
Table 57. Revenue (US$ Million) in Anticoagulant Medicines Business of AstraZeneca (2018-2024)
Table 58. AstraZeneca Recent Developments
Table 59. Bayer Basic Information List
Table 60. Bayer Description and Business Overview
Table 61. Bayer Anticoagulant Medicines Products, Services and Solutions
Table 62. Revenue (US$ Million) in Anticoagulant Medicines Business of Bayer (2018-2024)
Table 63. Bayer Recent Developments
Table 64. Boehringer Ingelheim Basic Information List
Table 65. Boehringer Ingelheim Description and Business Overview
Table 66. Boehringer Ingelheim Anticoagulant Medicines Products, Services and Solutions
Table 67. Revenue (US$ Million) in Anticoagulant Medicines Business of Boehringer Ingelheim (2018-2024)
Table 68. Boehringer Ingelheim Recent Developments
Table 69. Bristol-Myers Squibb Basic Information List
Table 70. Bristol-Myers Squibb Description and Business Overview
Table 71. Bristol-Myers Squibb Anticoagulant Medicines Products, Services and Solutions
Table 72. Revenue (US$ Million) in Anticoagulant Medicines Business of Bristol-Myers Squibb (2018-2024)
Table 73. Bristol-Myers Squibb Recent Developments
Table 74. Daiichi Sankyo Basic Information List
Table 75. Daiichi Sankyo Description and Business Overview
Table 76. Daiichi Sankyo Anticoagulant Medicines Products, Services and Solutions
Table 77. Revenue (US$ Million) in Anticoagulant Medicines Business of Daiichi Sankyo (2018-2024)
Table 78. Daiichi Sankyo Recent Developments
Table 79. Genentech (Roche) Basic Information List
Table 80. Genentech (Roche) Description and Business Overview
Table 81. Genentech (Roche) Anticoagulant Medicines Products, Services and Solutions
Table 82. Revenue (US$ Million) in Anticoagulant Medicines Business of Genentech (Roche) (2018-2024)
Table 83. Genentech (Roche) Recent Developments
Table 84. Johnson & Johnson. Basic Information List
Table 85. Johnson & Johnson. Description and Business Overview
Table 86. Johnson & Johnson. Anticoagulant Medicines Products, Services and Solutions
Table 87. Revenue (US$ Million) in Anticoagulant Medicines Business of Johnson & Johnson. (2018-2024)
Table 88. Johnson & Johnson. Recent Developments
Table 89. Lilly Basic Information List
Table 90. Lilly Description and Business Overview
Table 91. Lilly Anticoagulant Medicines Products, Services and Solutions
Table 92. Revenue (US$ Million) in Anticoagulant Medicines Business of Lilly (2018-2024)
Table 93. Lilly Recent Developments
Table 94. Merck Basic Information List
Table 95. Merck Description and Business Overview
Table 96. Merck Anticoagulant Medicines Products, Services and Solutions
Table 97. Revenue (US$ Million) in Anticoagulant Medicines Business of Merck (2018-2024)
Table 98. Merck Recent Developments
Table 99. Otsuka Basic Information List
Table 100. Otsuka Description and Business Overview
Table 101. Otsuka Anticoagulant Medicines Products, Services and Solutions
Table 102. Revenue (US$ Million) in Anticoagulant Medicines Business of Otsuka (2018-2024)
Table 103. Otsuka Recent Developments
Table 104. Pfizer Basic Information List
Table 105. Pfizer Description and Business Overview
Table 106. Pfizer Anticoagulant Medicines Products, Services and Solutions
Table 107. Revenue (US$ Million) in Anticoagulant Medicines Business of Pfizer (2018-2024)
Table 108. Pfizer Recent Developments
Table 109. Sanofi Basic Information List
Table 110. Sanofi Description and Business Overview
Table 111. Sanofi Anticoagulant Medicines Products, Services and Solutions
Table 112. Revenue (US$ Million) in Anticoagulant Medicines Business of Sanofi (2018-2024)
Table 113. Sanofi Recent Developments
Table 114. The Medicines Company Basic Information List
Table 115. The Medicines Company Description and Business Overview
Table 116. The Medicines Company Anticoagulant Medicines Products, Services and Solutions
Table 117. Revenue (US$ Million) in Anticoagulant Medicines Business of The Medicines Company (2018-2024)
Table 118. The Medicines Company Recent Developments
Table 119. North America Anticoagulant Medicines Market Size by Country (2018-2024) & (US$ Million)
Table 120. North America Anticoagulant Medicines Market Size by Country (2024-2029) & (US$ Million)
Table 121. Europe Anticoagulant Medicines Market Size by Country (2018-2024) & (US$ Million)
Table 122. Europe Anticoagulant Medicines Market Size by Country (2024-2029) & (US$ Million)
Table 123. Asia-Pacific Anticoagulant Medicines Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 124. Asia-Pacific Anticoagulant Medicines Market Size by Region (2018-2024) & (US$ Million)
Table 125. Asia-Pacific Anticoagulant Medicines Market Size by Region (2024-2029) & (US$ Million)
Table 126. Asia-Pacific Anticoagulant Medicines Market Share by Region (2018-2024)
Table 127. Asia-Pacific Anticoagulant Medicines Market Share by Region (2024-2029)
Table 128. Latin America Anticoagulant Medicines Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 129. Latin America Anticoagulant Medicines Market Size by Country (2018-2024) & (US$ Million)
Table 130. Latin America Anticoagulant Medicines Market Size by Country (2024-2029) & (US$ Million)
Table 131. Middle East & Africa Anticoagulant Medicines Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 132. Middle East & Africa Anticoagulant Medicines Market Size by Country (2018-2024) & (US$ Million)
Table 133. Middle East & Africa Anticoagulant Medicines Market Size by Country (2024-2029) & (US$ Million)
Table 134. Anticoagulant Medicines Market Trends
Table 135. Anticoagulant Medicines Market Drivers
Table 136. Anticoagulant Medicines Market Challenges
Table 137. Anticoagulant Medicines Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anticoagulant Medicines Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Anticoagulant Medicines Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Anticoagulant Medicines Market Share by Regions: 2022 VS 2029
Figure 4. Global Anticoagulant Medicines Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Anticoagulant Medicines Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Anticoagulant Medicines Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Anticoagulant Medicines Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Anticoagulant Medicines Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Anticoagulant Medicines Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of Injectable Anticoagulant Medicines
Figure 11. Global Injectable Anticoagulant Medicines Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Oral Anticoagulant Medicines
Figure 13. Global Oral Anticoagulant Medicines Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Global Anticoagulant Medicines Market Size Share by Type: 2022 & 2029
Figure 15. North America Anticoagulant Medicines Revenue Market Share by Type (2018-2029)
Figure 16. Europe Anticoagulant Medicines Revenue Market Share by Type (2018-2029)
Figure 17. Asia-Pacific Anticoagulant Medicines Revenue Market Share by Type (2018-2029)
Figure 18. Latin America Anticoagulant Medicines Revenue Market Share by Type (2018-2029)
Figure 19. Middle East and Africa Anticoagulant Medicines Revenue Market Share by Type (2018-2029)
Figure 20. Hospital Pharmacies Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 21. Retail Pharmacies Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 22. Online Pharmacies Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 23. Others Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 24. Global Anticoagulant Medicines Market Size Share by Application: 2022 & 2029
Figure 25. North America Anticoagulant Medicines Revenue Market Share by Application (2018-2029)
Figure 26. Europe Anticoagulant Medicines Revenue Market Share by Application (2018-2029)
Figure 27. Asia-Pacific Anticoagulant Medicines Revenue Market Share by Application (2018-2029)
Figure 28. Latin America Anticoagulant Medicines Revenue Market Share by Application (2018-2029)
Figure 29. Middle East and Africa Anticoagulant Medicines Revenue Market Share by Application (2018-2029)
Figure 30. Anticoagulant Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 31. Global Top 5 and Top 10 Players Anticoagulant Medicines Market Share in 2022
Figure 32. North America Anticoagulant Medicines Market Share by Country (2018-2029)
Figure 33. U.S. Anticoagulant Medicines Market Size (2018-2029) & (US$ Million)
Figure 34. Canada Anticoagulant Medicines Market Size (2018-2029) & (US$ Million)
Figure 35. Germany Anticoagulant Medicines Market Size (2018-2029) & (US$ Million)
Figure 36. France Anticoagulant Medicines Market Size (2018-2029) & (US$ Million)
Figure 37. U.K. Anticoagulant Medicines Market Size (2018-2029) & (US$ Million)
Figure 38. Italy Anticoagulant Medicines Market Size (2018-2029) & (US$ Million)
Figure 39. Russia Anticoagulant Medicines Market Size (2018-2029) & (US$ Million)
Figure 40. Nordic Countries Anticoagulant Medicines Market Size (2018-2029) & (US$ Million)
Figure 41. Asia-Pacific Anticoagulant Medicines Market Share by Region (2018-2029)
Figure 42. China Anticoagulant Medicines Market Size (2018-2029) & (US$ Million)
Figure 43. Japan Anticoagulant Medicines Market Size (2018-2029) & (US$ Million)
Figure 44. South Korea Anticoagulant Medicines Market Size (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Anticoagulant Medicines Market Size (2018-2029) & (US$ Million)
Figure 46. India Anticoagulant Medicines Market Size (2018-2029) & (US$ Million)
Figure 47. Australia Anticoagulant Medicines Market Size (2018-2029) & (US$ Million)
Figure 48. Latin America Anticoagulant Medicines Market Share by Country (2018-2029)
Figure 49. Mexico Anticoagulant Medicines Market Size (2018-2029) & (US$ Million)
Figure 50. Brazil Anticoagulant Medicines Market Size (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Anticoagulant Medicines Market Share by Country (2018-2029)
Figure 52. Turkey Anticoagulant Medicines Market Size (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Anticoagulant Medicines Market Size (2018-2029) & (US$ Million)
Figure 54. UAE Anticoagulant Medicines Market Size (2018-2029) & (US$ Million)
Figure 55. Bottom-up and Top-down Approaches for This Report